On the other hand, the distinct trajectory of DAT binding in the caudate across the age range of onset reported in our PD patients could imply a specific age-related effect on the dopaminergic function of the caudate nucleus, different from normal aging and independent of disease duration. This evidence concerns the gene SLC6A3 and Parkinson disease.